| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |